EP0030795A3
(en)
*
|
1979-12-06 |
1981-09-09 |
Imperial Chemical Industries Plc |
Quinoxaline derivatives, processes therefor, pharmaceutical compositions, and benzene derivatives
|
DE3032994A1
(de)
*
|
1980-09-02 |
1982-04-22 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue pyrazino-azepine, deren herstellung und diese sie enthaltende arzneimittel
|
JPS62198671A
(ja)
*
|
1986-02-25 |
1987-09-02 |
Toyo Jozo Co Ltd |
1−置換アルキル1,2−ジヒドロ−2−ピラジノン誘導体
|
JPS62281878A
(ja)
*
|
1986-02-26 |
1987-12-07 |
Taisho Pharmaceut Co Ltd |
アザアントラセン化合物
|
JPH0678319B2
(ja)
*
|
1986-03-11 |
1994-10-05 |
東ソー株式会社 |
キノキサリノン誘導体
|
JPS6450868A
(en)
*
|
1987-08-21 |
1989-02-27 |
Toyo Jozo Kk |
1-substituted alkyl-2-oxo-1,2-dihydroquinoxaline derivative
|
JPH0276860A
(ja)
*
|
1987-10-05 |
1990-03-16 |
Toyo Jozo Co Ltd |
6−置換アルコキシ−2−オキソ−1,2−ジヒドロキノキサリン誘導体
|
NO179551C
(no)
*
|
1987-11-10 |
1996-10-30 |
Novo Nordisk As |
Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
|
GB9413975D0
(en)
|
1994-07-11 |
1994-08-31 |
Fujisawa Pharmaceutical Co |
New heterobicyclic derivatives
|
AU9049391A
(en)
*
|
1990-12-20 |
1992-07-22 |
Warner-Lambert Company |
2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
|
DE4217952A1
(de)
*
|
1992-05-30 |
1993-12-02 |
Basf Ag |
Chinoxalin-2,3(1H,4H)-dione
|
FR2696456B1
(fr)
*
|
1992-10-07 |
1995-01-06 |
Pf Medicament |
Dérivés de dihydro-1,2 oxo amino-3 quinoxalines, leur préparation et leur application en thérapeutique.
|
DE4340045A1
(de)
*
|
1993-11-24 |
1995-06-01 |
Basf Ag |
Neue Chinoxaline und Arzneimittel daraus
|
US5620978A
(en)
*
|
1994-01-03 |
1997-04-15 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon |
8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor
|
GB2291422A
(en)
*
|
1994-07-18 |
1996-01-24 |
Fujisawa Pharmaceutical Co |
4-phenyl-pyrido[2,3-b]pyrazin-4-ones
|
FR2731221B1
(fr)
*
|
1995-03-01 |
1997-05-30 |
Pf Medicament |
Nouveaux derives de l'ethyl-1 dihydro-1, 2 oxo-2 methylamino-3 quinoxaline, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
|
GB9526558D0
(en)
*
|
1995-12-27 |
1996-02-28 |
Fujisawa Pharmaceutical Co |
Heterobicyclic derivatives
|
ZA973884B
(en)
*
|
1996-05-23 |
1998-11-06 |
Du Pont Merck Pharma |
Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
|
EP1380298A3
(en)
*
|
1996-05-23 |
2004-04-07 |
Bristol-Myers Squibb Pharma Company |
Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders, anorexia, inflammation
|
US5869487A
(en)
*
|
1996-10-24 |
1999-02-09 |
Merck & Co., Inc. |
Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
|
US6087373A
(en)
*
|
1997-09-23 |
2000-07-11 |
Merck & Co., Inc. |
Thrombin inhibitors
|
TR200200971T2
(tr)
*
|
1998-09-29 |
2002-06-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Piridopirazan bileşiğinin yeni tuzları ve bunların kristalleri.
|
US6239132B1
(en)
|
1999-04-23 |
2001-05-29 |
Merck & Co., Inc. |
Thrombin inhibitors
|
EP1189618A4
(en)
|
1999-06-04 |
2002-06-19 |
Merck & Co Inc |
thrombin
|
RU2003135424A
(ru)
*
|
2001-05-14 |
2005-05-20 |
Бристол-Маерс Сквибб Фарма Компани (Us) |
Замещенные пиразиноны, пиридины и пиримидины в качестве лигандов кортикотропин высвобождающего фактора
|
SE0302323D0
(sv)
*
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
SE0302324D0
(sv)
*
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
SE0302486D0
(sv)
|
2003-09-18 |
2003-09-18 |
Astrazeneca Ab |
Novel compounds
|
JP2007507514A
(ja)
*
|
2003-09-30 |
2007-03-29 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キノキサリン化合物
|
CA2543710A1
(en)
*
|
2003-11-03 |
2005-05-12 |
Warner-Lambert Company Llc |
Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
|
PT1711184E
(pt)
*
|
2004-01-06 |
2007-09-24 |
Janssen Pharmaceutica Nv |
''derivados de ( 3-oxo-3, 4-di-hidro-quinoxalin-2-il-amino)-benzamina e compostos relacionados como inibidores da fosforilase do glicogénio para o tratamento da diabetes e da obesidade''
|
PA8640801A1
(es)
*
|
2004-08-09 |
2006-08-03 |
Warner Lambert Co |
Nuevos inhibidores de la recaptacion de norepinefrina de quinoxalinona para el tratamiento de trastornos del sistema nervioso central
|
US7601716B2
(en)
*
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
TW200808763A
(en)
|
2006-05-08 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds I
|
TW200808771A
(en)
|
2006-05-08 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds II
|
DE102007050673A1
(de)
|
2007-10-19 |
2009-04-23 |
Friedrich-Schiller-Universität Jena |
Neue Hexaaza-acene und Verfahren zu ihrer Herstellung
|
CL2008003301A1
(es)
|
2007-11-06 |
2009-10-16 |
Astrazeneca Ab |
Compuestos derivados de 3,4-dihidropirazina-2-carboxamida, inhibidores de la elastasa de neutrofilos humanos; composiciones farmacéuticas; procesos de preparación de compuestos y composición farmacéutica; y uso en el tratamiento de síndrome de dificultad respiratoria de los adultos, fibrosis quística, cáncer, entre otras.
|
ES2632964T3
(es)
|
2008-03-05 |
2017-09-18 |
Merck Patent Gmbh |
Derivados de piridopirazinonas estimuladores de la secreción de insulina, métodos para obtenerlos y uso de los mismos para el tratamiento de la diabetes
|
PT2250156E
(pt)
*
|
2008-03-05 |
2015-09-09 |
Merck Patent Gmbh |
Derivados de pirazinona como estimuladores da secreção de insulina, métodos para a sua obtenção e utilização destes para o tratamento de diabetes
|
TW201036957A
(en)
|
2009-02-20 |
2010-10-16 |
Astrazeneca Ab |
Novel salt 628
|
JP5548685B2
(ja)
|
2009-06-26 |
2014-07-16 |
イハラケミカル工業株式会社 |
ケトマロン酸化合物又はその抱水体の製造法
|
WO2011039528A1
(en)
|
2009-10-02 |
2011-04-07 |
Astrazeneca Ab |
2-pyridone compounds used as inhibitors of neutrophil elastase
|
JP5921500B2
(ja)
|
2013-07-19 |
2016-05-24 |
イハラケミカル工業株式会社 |
ケトマロン酸化合物の製造方法
|
JP6017710B2
(ja)
|
2014-02-17 |
2016-11-02 |
イハラケミカル工業株式会社 |
流通反応器を用いたケトマロン酸化合物の連続製造方法
|
EP3394046B1
(en)
*
|
2015-12-24 |
2022-03-09 |
The Regents Of The University Of California |
Cftr regulators and methods of use thereof
|
US11839616B2
(en)
|
2017-08-24 |
2023-12-12 |
The Regents Of The University Of California |
Ocular pharmaceutical compositions
|